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ABSTRACT 
Objectives: Terminalia chebula (TCh) and Phyllanthus emblica (PE) posses wide range of central nervous system activity. This study was conducted 
to investigate the antidepressant activity and mechanism action of aqueous extract of TCh & PE using forced swimming test (FST) and tail 
suspension test (TST).  
Methods: Aqueous extracts of TCh (390, 780 & 1560mg/kg) and PE (390, 780, 1560 & 3120 mg/kg) were administered for seven days to mice and 
immobility time was measured in FST & TST. Extracts were administered for 14 days and immobility time was measured in chronic FST. The 
mechanisms of antidepressant effect of TCh and PE were studied using prazosin (1mg/kg), levosulpiride (20mg/kg) and p-CPA (300mg/kg) in TST.  
Results: In FST, 780 & 1560 mg/kg of TCh and 1560 & 3120 mg/kg of PE reduced immobility time while in TST, 1560 mg/kg of TCh and 3120 
mg/kg of PE decreased immobility significantly compared to control. In chronic FST, only 780 & 1560 mg/kg of TCh showed significant reduction. 
Antidepressant effect of TCh was reversed by prazosin while antidepressant effect of PE was reversed by prazosin and levosulpiride significantly in 
TST.  
Conclusions: The aqueous extracts of TCh and PE possess antidepressant activity at higher doses. This effect was possibly mediated through mono 
aminergic pathways. 
Keywords: Animal models of depression, Forced swimming test, Phyllanthus emblica, Tail suspension test, Terminalia chebula. 
 
INTRODUCTION 
According to World Health Organisation, depression affects about 
121 million people worldwide and it is among the leading causes of 
disability. By 2020, it would become the second leading contributor 
to global burden of disease in the world after cardiovascular 
diseases [1]. Currently, major groups of antidepressants used for 
treatment of depression include selective serotonin reuptake 
inhibitors (e.g. citalopram, sertraline, and Fluoxetine), tricyclic 
antidepressants (e.g. amitriptyline, imipramine and nortriptyline), 
monoamine oxidase inhibitors (e.g. phenelzine, moclobemide) and 
other newer heterocyclic antidepressants. The modern 
antidepressants are associated with untoward adverse effects 
including drowsiness, dry mouth, urinary retention, cardiac 
arrhythmias, gastro-intestinal upset, sexual dysfunction and they 
pose risk of overdose in vulnerable patients [2]. An estimated 29 to 
46% of patients treated for major depressive disorder have either a 
partial response or no response at all to anti-depressive treatment 
[3]. Hence, there is a continued need to search for an antidepressant 
drug which is more effective and safe. 
Terminalia chebula (TCh) and Phyllanthus emblica (PE) are claimed 
to possess wide range of central nervous system activity and are 
recommended for ‘Mastishka Dourbalya’ (weakness of brain and 
nerves) which may be correlated with disorders like Alzheimer’s 
disease, amnesia and dementia as per Ayurvedic text [4]. The 
extracts of the air-dried fruit of T. chebula Retzius (water, methanol, 
and 95% ethanol) have shown neuroprotective activity in 
experimental model of ischemic neuronal damage [5]. A polyherbal 
preparation BR-16 (Mentat) containing TCh and PE has been 
evaluated in models of anxiety and depression [6]. Literature search 
revealed that there is no experimental study reporting evaluation of 
antidepressant potential of single formulation of TCh. PE is 
advocated for a number of disease conditions in Ayurveda. It is 
widely used in the Indian subcontinent and is known to be safe on 
chronic consumption [7]. PE in the form of Anwala churna (an 
ayurvedic preparation) has been evaluated in models of memory 
and learning [8]. Earlier experimental studies have shown that 
hydro-alcoholic extract of PE (Gaertn) has also been tested for its 
antiepileptic activity [9]. Two groups of researchers have reported 
antidepressant-like effect of aqueous extract of fruits of PE in animal 
models of depression [10, 11].  
Both TCh and PE are described as rasayanas (agents promoting 
longevity, resistance against infections and enhancing memory and 
intellect) in Ayurveda and have been shown to be useful as 
‘adaptogens’ in animal models of stress [12-14]. Adaptogens help to 
counteract any adverse physical, chemical or biological stressor by 
generating non-specific resistance and allow the body to adapt to 
diverse demands imposed on it [14, 15]. Knowing the association of 
chronic stress and development of depression [16], the idea was 
conceived that adaptogen plants- TCh and PE may possibly have a 
role in therapy of depression. 
Hence, in view of the above considerations, the present study was 
planned to evaluate antidepressant effect of TCh and also to 
strengthen the evidence about the antidepressant effect of PE; in 
behavioural models of depression in mice. It was also decided to find 
out mechanism of antidepressant activity of TCh and PE using 
monoaminergic antagonists.  
MATERIALS AND METHODS 
Animals used 
After approval from the Animal Ethics Committee of the Institute, 
216 Swiss albino mice of either sex (weighing 25-35 g) were 
procured and housed in the Central Animal House of the Institute 
maintained according to guidelines laid down by the Committee for 
the Purpose of Control and Supervision of Experiments on Animals 
(CPCSEA), India. The animals were housed in groups of 6 mice per 
cage in polypropylene cages with husk of paddy as the bedding. The 
animals were fed with food pellets (procured from Chakan Oil Mills, 
Maharashtra) and received filtered and UV purified water ad libitum. 
Temperature of the Animal House was maintained at 22 ± 3°C, with 
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50-70% humidity, with 12-15 filtered fresh air changes per hour and 
12 hour light/dark cycles. 
Study drugs used 
The plant drugs selected for evaluation were standardized aqueous 
extracts of dried fruits of the two plants, TCh (extractive value- 45%) 
and PE (extractive value- 35%); purchased from Natural Remedies 
Ltd., Bengaluru, India. The extracts were stored at room temperature 
in a desiccator containing sodium bicarbonate to avoid moisture. 
TCh extract contained 13.0% (w/w) of gallic acid, 49.2 % (w/w) and 
the moisture content was 4.7% (w/w). PE extract contained 11.5 % 
(w/w) of gallic acid and 36.8 % (w/w) of Tannins as tannic acid with 
moisture content of 2.6% (w/w). The doses of the extracts were 
derived based on the doses advocated for humans as per ayurvedic 
text [4, 17]. Three different doses of the TCh and four doses of PE 
were chosen for this study. Fluoxetine (Sun Pharmaceuticals Ltd., 
India) was selected as the positive control. TCh, PE and fluoxetine; 
dissolved in distilled water were administered orally once daily at 
the same time of the day (between 9.30 am to 11.30am) (Table 1). 
Prazosin (alpha adrenergic antagonist) procured from Sun 
Pharmaceuticals Ltd., India; levosulpiride (selective D2 receptor 
antagonist) obtained from Intaas Pharmaceuticals, India - and p-
chlorophenylalanine (serotonin synthesis inhibitor) purchased from 
Sigma-Aldrich, USA was used to study mechanisms of antidepressant 
effect of TCh and PE. Prazosin, levosulpiride and p-CPA were 
administered orally in distilled water. 
 
Table 1: Part 1: Experimental groups for FST, TST and chronic FST 
Group(N= 6) Study Drugs Dose (mg/kg/day) 
1 Distilled water 0.5 ml 
2 Fluoxetine 20 
3 TCh -1 390 
4 TCh -2 780 
5 TCh -3 1560 
6 PE -1 390 
7 PE -2 780 
8 PE -3 1560 
9 PE -4 3120 
TCh- Terminalia chebula, PE- Phyllanthus emblica 
 
Prazosin and levosulpiride were administered once 45 minutes 
before conducting tail suspension test and p-CPA was administered 
3 times; 72, 48 and 24 hours prior to tail suspension test [18]. The 
study doses of drugs are shown in Table 2. 
 
Table 2: Part 2: Experimental groups for study of mechanism of action of TCh and PE 
Group(N=6) Study Drugs Dose 
1 DW 0.5 ml 
2 TCh -3 780 mg/kg 
3 PE -4 3120 mg/kg 
4 Prazosin+ DW 1mg/kg + 0.5 ml 
5 Levosulpiride + DW Levosulpiride + 0.5 ml 
6 p-CPA + DW 300mg/kg + 0.5 ml 
7 Prazosin + TCh -3 1 mg/kg + 780 mg/kg 
8 Levosulpiride + TCh -3 20 mg/kg + 780 mg/kg 
9 p-CPA + TCh -3 300 mg/kg + 780 mg/kg 
10 Prazosin + PE -4 1 mg/kg + 3120 mg/kg 
11 Levosulpiride + PE -4 20 mg/kg + 3120 mg/kg 
12 p-CPA + PE -4 300 mg/kg + 3120 mg/kg 
DW- Distilled water, TCh- Terminalia chebula, PE- Phyllanthus emblica, p-CPA- p-chlorophenylalanine. 
 
Study Procedures 
The study was divided into 2 parts. In the part 1, antidepressant 
effect of TCh and PE was evaluated in the models of forced 
swimming test (FST) and tail suspension test (TST). In part 2, 
mechanisms of antidepressant action of TCh and PE were studied 
using prazosin, levosulpiride and p-CPA in the model of TST. 
Part 1- Antidepressant activity in forced swimming tests and 
tail suspension test  
Forced swimming test 
The mice were randomly divided into 9 groups (6 /group). Modified 
version of the forced swimming test (FST) was used in the study [19]. 
The study groups were administered the respective drugs: distilled 
water (vehicle control), fluoxetine (positive control), TCh (three groups) 
were and PE (four groups); orally for 7 consecutive days (Table 1). On 
day 6, pre-test session was conducted wherein mice were forced to swim 
for 15 minutes in a 25 cm tall, 12 cm diameter glass cylinder filled to 15 
cm with water (temperature 25°C ± 3°C). After the 15 min pre-test 
session, mice were removed from the water, wiped with towels and 
placed under a warming lamp until dry. On 7th day, 60 minutes following 
administration of the study drugs, immobility time was noted in all mice 
for five minutes. Immobility was defined as the time spent by mice 
making only movements necessary to keep their head above water. The 
water in the glass cylinder was changed after each swimming session. 
Open field test for measurement of locomotor activity [20] 
Open field test (OFT) was conducted in the mice, 5 min before 
subjecting them to FST. The open field apparatus is made of wooden 
box (36 X 36 X 30 cm high). Its floor is divided into nine squares of 
equal dimensions (12 X 12 cm). For OFT, each mouse was placed in 
the centre of arena. The locomotor activity of each mouse was 
assessed by counting the number of line crossings and rearing 
frequencies in the open field apparatus for 5 minutes. The apparatus 
was cleaned after each assessment to eliminate the possibility of any 
odor clues left by the previously tested mice. The experiments were 
conducted in dark and sound proof room. 
Tail suspension test [19, 21] 
Fifty-four mice were randomly divided into 9 groups (6/group).Tail 
suspension test (TST) was conducted according to the procedure 
described by Steru et al [22]. The study drugs were administered to 
the respective groups orally for 7 consecutive days at the same time 
of the day (Table 1). On 7th day, 60 minutes following 
administration of the study drugs, immobility time was noted in TST 
over a period of six minutes. Mice were considered immobile only 
when they hung passively and were completely motionless. 
Chronic forced swimming test  
A method devised by Kitamura et al. [23] was used to conduct 
chronic version of the FST. The mice were randomly allocated to 9 
groups (6/group) (Table 1).The study drugs were administered 
orally, once every day for 14 days and the mice were forced to swim 
in the glass cylinder for 6 minutes every day for 13 days. On the day 
of test (i.e. day 14 of study drug administration), one hour following 
the study drug administration; test session of 6 min was conducted. 
Immobility time was measured for six minutes. The water in the 
glass cylinder was changed after each swimming session. 
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Part 2- Mechanism of antidepressant action of TCh and PE using 
prazosin, levosulpiride and p-chlorophenylalanine alone and in 
combination with TCh in TST [18] 
The study drugs were administered to the respective groups orally 
for 7 consecutive days at the same time of the day (Table 2). TCh 
and PE were administered in the highest doses which were found to 
be effective in part 1 of the study for a period of 7 days. Prazosin and 
levosulpiride were administered intraperitoneally once 45 minutes 
and p-CPA was administered intraperitoneally 3 times; 72, 48 and 
24 hours prior to the test session. All the observations in part 1 and 
2 of the study were made by a trained observer who remained 
unaware of treatment allocation. 
Statistical Analysis 
The results were expressed as mean ± standard deviation (SD) 
values which were compared using one way ANOVA followed by 
post hoc Tukey's test using the Graph Pad Instat version 3.06. A ‘p’ 
value of <0.05 was considered significant. 
RESULTS 
Part 1- Antidepressant activity of TCh and PE 
Forced Swimming Test 
Treatment of mice with fluoxetine produced a significant reduction 
(p<0.01) in the immobility time compared to vehicle control 
(p<0.001). TCh-1 group showed small reduction in immobility time 
compared to control. The two higher doses of TCh-2 and TCh-3 led 
to significant reduction in immobility time compared to vehicle 
control (p<0.01) and the mean values of immobility time in both 
these groups were comparable to those in the fluoxetine treated 
group. There was a trend towards decline in immobility time 
observed with increasing doses of PE in the four PE groups. 
However, only the two higher dose groups, PE-3 (p<0.05) and PE-4 
(p<0.001) showed significant reduction in duration of immobility 
when compared to the control. The immobility time in both PE-3 and 
PE-4 groups was found to be comparable to that in the fluoxetine 
treated group (Table 3). 
 
Table 3: Effect of TCh and PE on immobility time in FST 
Groups 
n=6 
Drugs Duration of immobility in seconds 
(Mean + S.D) 
1 D/W 204.67 ± 16.95 
2 FLU 141.67 ± 11.59** 
3 TCh- 1 179.00 ± 22.39 NS 
4 TCh- 2 157.33 ± 28.25 * NS1 
5 TCh- 3 154.00 ± 16.91 * NS1 
6 PE- 1 212.33 ± 20.10 NS 
7 PE -2 173.17 ± 28.53 NS 
8 PE -3 168.67 ± 20.36* NS1 
9 PE- 4 138.67 ± 16.40** NS1 
D/W: Distilled water, FLU: fluoxetine, TCh: Terminalia chebula, 
*p<0.01, **p<0.001 vs D/W group, NS - Not significant vs D/W 
group, NS1- Not significant vs FLU group, One way ANOVA with post 
hoc Tukey’s test. 
 
Open field test 
Treatment with fluoxetine, TCh and PE at all doses did not show any 
difference in the number of line crossings and rearing frequencies as 
compared to control group treated with distilled water (Table 4).
 
Table 4: Effect of TCh& PE on line crossing and rearing frequencies in OFT 
Groups 
n=6 
Drugs Number of line 
Crossings (mean + S.D.) 
Number of rearing frequencies (mean + S.D.) 
1 D/W 85.83 ± 20.27 27.17 ± 14.61 
2 FLU 64.67 ± 21.82 NS 16.83 ± 4.59 NS 
3 TCh -1 78.83 ± 20.51 NS 23.00 ± 7.46 NS 
4 TCh - 2 87.17 ± 18 NS 20.17 ± 6.08 NS 
5 TCh -3 67.17 ± 17.96 NS 19.17 ± 4.36 NS 
6 PE- 1  76.17 ± 15.48 NS 27.50 ± 9.01 NS 
7 PE - 2  77.17 ± 19.21 NS 30.00 ± 10.66 NS 
8 PE- 3  66.00 ± 11.83 NS 18.67 ± 4.50 NS 
9 PE - 4 85.17 ± 5.81 NS 23.67 ± 5.47 NS 
D/W: Distilled water, FLU: fluoxetine, TCh: Terminalia chebula, NS - Not significant vs D/W group, One-way ANOVA with post hoc Tukey’s test. 
 
Tail suspension test: As shown in Table 5, fluoxetine treated group 
caused a significant reduction in immobility time as compared to 
control (p<0.001). In TCh-1 and TCh-2 groups, there was no 
decrease in duration of immobility compared to control. TCh-3 
group showed significant reduction in immobility time versus 
control (p<0.01). However, the reduction in immobility time in 
fluoxetine group was far more than that observed in the TCh-3 
group. The PE-1, PE-2 and PE-3 groups did not produce any decrease 
in immobility time as compared to control. Although the PE-4 group 
showed significant reduction in immobility time compared to vehicle 
control (p<0.001), the extent of reduction was lesser when 
compared with that of fluoxetine group. 
 
Table 5: Effect of TCh and PE on immobility time in TST 
Groups 
n=6 
Drugs Duration of immobility in seconds 
(Mean + S.D.) 
1 D/W 202.33 ± 21 
2 FLU  62.83 ± 20.76** 
3 TCh -1 194.83 ± 28.82 NS 
4 TCh -2 159.67 ± 21.79 NS 
5 TCh -3  136 ± 32.12 * † 
6 PE -1 182.83 ± 32.82 NS 
7 PE -2 167.00 ± 22.51 NS 
8 PE -3 171.33 ± 17.14 NS 
9 PE -4 133.67 ± 12.32* † 
D/W: Distilled water, FLU: fluoxetine, TCh: Terminalia chebula, * p<0.01, ** p<0.001 vs D/W group. †p< 0.001 vs FLU group, NS- Not significant vs 
D/W group, One-way ANOVA with post hoc Tukey’s test. 
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Chronic forced swimming test: Treatment with fluoxetine 
produced a reduction in immobility time (p<0.001). TCh-1 treatment 
did not cause any decrease in duration of immobility as compared to 
the control group. TCh-2 (p<0.05) and TCh-3 (p<0.001) groups 
showed significant reduction in immobility time compared to 
control which was significantly less than that observed in fluoxetine 
group. The three PE treated groups: PE-1, PE-2 and PE-4 showed no 
reduction in the duration of immobility as compared to the vehicle 
control. A small (statistically insignificant compared to control) 
decrease in immobility time was observed in PE-3 group (Table 6). 
 





Duration of immobility in seconds 
(mean ± S.D.) 
1 D/W 229.17 ± 9.93 
2 FLU 156.00 ± 23.23 *** 
3 TCh -1 216.50 ± 13.92 NS 
4 TCh -2 203.67 ± 11.45 * †† 
5 TCh -3 192.67 ± 8.66 ** † 
6 PE -1 218.00 ± 22.11NS 
7 PE -2 226.17 ± 24.19 NS 
8 PE -3 201.17 ± 11.29 NS 
9 PE -4 217.00± 11.85 NS 
D/W: Distilled water, FLU: fluoxetine, TCh: Terminalia chebula, *p<0.05, **p<0.01, ***p<0.001 vs D/W group. †p< 0.01, ††p< 0.001 vs FLU group, NS – 
Not significant vs D/W group, One-way ANOVA used with post hoc Tukey’s test. 
 
Part 2-Mechanism of antidepressant action of TCh and PE 
Based on the Part 1 results, the highest doses of TCh (TCh-3) and PE 
(PE- 4) were selected to elucidate mechanism of antidepressant 
action of TCh and PE. The vehicle control group showed immobility 
time of 202.33±21. TCh-3 group showed significantly less immobility 
time (136.00 ±32.12) compared to the control group (p <0.01). 
Prazosin, levosulpiride and p-CPA per se did not produce any change 
in immobility time as compared to vehicle control. Treatment of 
TCh-3 pretreated mice with prazosin caused increase in immobility 
time which was significantly more (181.67±14.40) as compared to 
TCh-3 group. TCh-3 with levosulpiride and TCh-3 with p-CPA did not 
produce any significant change in immobility time as compared to 
TCh-3 group (Table 7). 
 
Table 7: Effect of combination of TCh with prazosin, levosulpiride and p-CPA on immobility time in TST in mice 
Groups n=6 Drugs Immobility time in seconds (mean ± S.D) 
1 D/W 202.33 ± 21.00 
2 Prazosin + D/W 214.17 ± 18.52 NS 
3 Levosulpiride + D/W 191.00 ± 14.70 NS 
4 p-CPA + D/W 222.33 ± 16.49 NS 
5 TCh -3 136.00 ± 32.12* 
6 Prazosin + TCh -3 181.67 ± 14.40† 
7 Levosulpiride + TCh -3 154.33 ± 16.10 NS1 
8 p-CPA + TCh -3 167.67 ± 17.55 NS1 
D/W: distilled water, p-CPA: p-chlorophenylalanine, TCh-3: Terminalia chebula-1560 mg/kg, NS -Not significant vs D/W group, *p<0.01 vs D/W 
group, †p<0.01 vs TCh–3 group, NS1-Not significant vs TCh–3 group. Data are expressed as mean ± S.D.. One-way ANOVA used with post hoc Tukey’s 
test
PE- 4 group showed significantly less immobility time of 133.67 ± 12.32 
compared to the control group (p <0.001). Treatment of PE-4 pretreated 
mice with prazosin (166.00 ±11.80) and p-CPA (178.83 ± 17.06) (except 
levosulpiride); produced increased immobility times and the values 
were significantly higher as compared to PE-4 group (Table 8). 
Table 8: Effect of combination of PE with prazosin, levosulpiride 
and p-CPA on immobility time in TST in mice 
Groups 
n=6 
Drugs Immobility time in seconds (mean 
± S.D) 
1 D/W  202.33 ± 21.00 
2 Prazosin + D/W 214.17 ± 18.52 NS 
3 Levosulpiride + 
D/W 
191.00 ± 14.70 NS 
4 p-CPA + D/W 222.33 ± 16.49 * 
5 PE -4 133.67 ± 12.32** 
6 Prazosin + PE -4  166.00 ± 11.80† 
7 Levosulpiride + 
PE -4 
158.00 ± 19.42 NS1 
8 p-CPA + PE -4 178.83 ± 17.06 †† 
D/W: distilled water, p-CPA: p-chlorophenylalanine, PE-4: 
Phyllanthus emblica-3120 mg/kg, NS – Not significant, *p <0.05, **p 
<0.001 vs D/W group, † p <0.05, †† p <0.01, NS1- Not significant vs PE 
-4 group, One-way ANOVA with post hoc Tukey’s test. 
DISCUSSION 
In the present study, three graded doses of TCh (the lowest and 
highest therapeutic dose extrapolated from human doses as per 
Ayurveda literature and two times the highest dose) and four 
different doses of PE (the lowest and highest therapeutic doses as 
per Ayurveda literature, two and four times the highest dose) were 
chosen for the study. Previous experimental studies with TCh have 
used the dose range of 50 mg/kg to 800 mg/kg [24, 25].  
PE has been evaluated in the models of depression in the dose range 
of 0.8 mg/kg [10] to 400 mg/kg [11] in previous studies. A broader 
and higher dose range of both the plant drugs compared to previous 
studies were selected in the present in order to study effects 
appearing at higher doses and identify dose dependent action. The 
models of FST and TST which are widely used for screening of 
antidepressant drugs were selected in the present study [19, 26]. Open 
field test (OFT) is performed to test locomotor activity to rule out 
nonspecific stimulant effect of plant extracts as most antidepressant 
drugs do not increase locomotor activity in OFT [27, 28]. 
The results of the study showed that aqueous extract of fruit of TCh 
at the doses of 780 and 1560 mg/kg produced significant 
antidepressant effects in FST and chronic FST but it failed to show 
any effect at lowest dose (390 mg/kg). The highest dose of TCh 
(TCh-3) produced the most consistent effect in all models. The effect 
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of TCh-3 was significantly reversed by administration of prazosin 
indicating that the antidepressant effect of TCh may be mediated 
through noradrenergic transmission by interaction with alpha-1 
adrenoceptors in brain. TCh effect does not appear to be mediated 
through dopaminergic and serotonergic systems because 
levosulpiride and p-CPA did not increase the immobility time in TCh 
pre-treated mice. Aqueous extract of fruit of PE showed 
antidepressant effect at higher doses (1560 and 3120 mg/kg) but 
failed to show any effect at lower doses (390 and 780 mg/kg). It was 
surprising that in chronic FST, there was no reduction in immobility 
with PE-4. West et al have hypothesized that behavior of immobility 
in a water cylinder reflects a learned habituation taking place in an 
environment that has become more familiar to animal which leads to 
decrease in immobility [29]. However, it is difficult to explain why 
we did not find similar habituating effect in TCh-3 and TCh-4 groups. 
It was observed that effect of PE was reversed by prazosin and p-
CPA and not by levosulpiride. This finding suggests that PE possibly 
exerts its antidepressant effectby interacting with alpha-1 
adrenoceptors and to increase in serotonin (5-HT) synthesis in the 
brain. The comparable observations related to line crossings and 
rearing frequencies among all the study groups in the OFT excluded 
the possibility of general stimulant activity of TCh and PE. 
Conventionally, hypotheses on the pathophysiology of mood 
disorders are based on aberrant intra-synaptic concentrations of the 
neurotransmitters serotonin and norepinephrine. However, recent 
neuroimaging and post mortem morphometric studies have 
demonstrated selective structural and morphological (macroscopic 
and microscopic) changes across various limbic and non-limbic 
circuits in the brains of depressed patients. Stress and 
antidepressant treatment have an opposite effect on the intracellular 
signaling, transcription factors and target genes. An evolving new 
hypothesis in the pathophysiology and treatment of depression 
involves adaptation or plasticity of neural systems. Depression could 
result from an inability to make the appropriate adaptive responses 
to stress or aversive stimuli. It is possible that antidepressant 
treatment could oppose these adverse cellular effects, which may be 
regarded as a loss of neural plasticity, by blocking or reversing the 
atrophy of neurons and by increasing cell survival and function [30].  
There is an evidence of derangement of oxidant and antioxidant 
defense systems in depression [30]. It is speculated that some 
phytoconstituents present in TCh and PE extracts having antioxidant 
and neoroprotective effects may also contribute to antidepressant 
mechanism [31- 33]. 
We compared our findings with other studies reported in literature. 
To the best of our knowledge, there is no study reported with TCh. In 
a study by Dhingra et al [11] the aqueous extract of fruit of PE 
showed decreased immobility period in both tail suspension test and 
forced swim test which was postulated to be due to interaction of PE 
with α1-adrenoceptors, dopamine D2-receptors, serotonergic, and 
GABAB receptors whereas our study results indicated possible 
interaction only with adrenoceptors and serotonergic receptors. 
Dhingra et al also observed a significant decrease in brain MAO-A 
levels in animals treated with PE [11]. In another study by 
Pemminati et al aqueous extract of fruits of PE was found to be more 
effective than imipramine in the models of TST and FST [10]. 
However in our study, although PE was effective at higher doses, the 
effect was smaller as compared to fluoxetine. The variations in 
responses obtained with PE in this study as compared to the 
previous two studies are difficult to explain but may be attributed to 
different doses used by us. Tannic acid is known to produce 
nonselective inhibition of monoamine oxidase, thereby increasing 
the levels of monoaminergic neurotransmitters in the brain [10]. 
This fact explains the effect of PE in decreasing brain MAO-A levels 
in study by Dhingra et al [11]. Facilitation of monoaminergic 
transmission through effect on MAO-A enzymes and / or decrease 
neuronal reuptake of serotonin could be other mechanisms 
mediating antidepressant effects of TCh and PE which were not 
explored in the present study.  In the present study, we have shown 
the antidepressant effect of TCh for the first time. Our findings also 
corroborate with the evidence available for PE for its antidepressant 
potential. A wide dose range of TCh and PE in animal models of 
depression have been evaluated in this study for the first time. It is 
necessary to confirm safety profile of wide dose range of TCh and 
PEused in this study by carrying out detailed toxicity studies. It will 
be worthwhile to carry out further studies to confirm antidepressant 
effects of TCh and PE in other established models of depression and 
also study their interaction with modern antidepressants. The 
possible mechanism of antidepressant action of TCh and PE may be 
through modulation of monoaminergic pathways as shown in this study. 
Individual phyto-constituents of TCh and PE by virtue of their 
antioxidant and neurotropic properties may also be contributing to 
antidepressant effect and these properties need to be investigated 
further.  
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